Efficacy and Tolerability of Peginterferon α-2a and Peginterferon α-2b, Both plus Ribavirin, for Chronic Hepatitis C: A Meta-Analysis of Randomized Controlled Trials
Table 2
Baseline characteristics in the two groups of peginterferon α-2a and peginterferon α-2b in this meta-analysis.
NA: not available; BMI: Body mass index; †Ishak score S5, 6. F0–4 (F0: no fibrosis; F1: portal fibrosis without septa; F2: portal fibrosis with few septa; F3: numerous septa without cirrhosis; F4: cirrhosis). All baseline characteristics were comparative between the two groups.